Search
Search your stock
Analysis
West Pharmaceutical Services, Inc. (WST)
West Pharmaceutical Services, Inc. (WST)
Ranking:
Sell
Implies negative momentum
Stock Name: West Pharmaceutical Services, Inc.
Symbol: WST
Market Cap: $23.72B
Industry: Medical - Instruments & Supplies
Sector: Healthcare
Website: https://www.westpharma.com
About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components Please visit their website for more information.

Overview:
Last Close: $327.57
52 Week: $276.98-$412.52
MVA50: 307.47
MVA200: 324.13
RSI: 59.89
Buy/Sell*: 56.38
1-Month change: 8.48%
3-Month change: 2.38%
*Proprietary Buy Sell Volume Indicator
Price Chart For WST
Financial Parameters Most Recent Quarter: (2024-Q3),2024-09-30
Revenue: $747M
Revenue Growth (YOY): -0.07%
Profit (% of Rev): 35.44%
Income (% of Rev): 18.21%
Income Growth (YOY): -15.69%
Operating Income: $161M
Operating Cash Flow: $180M
Operating Cash Flow Growth (YoY): -21.73%
Annual Dividend Yield: 0.07%
Total Assets: $3.68B
Total Liabilities: $923M
Cash & Equivalent: $491M
Total Debt: $203M
Debt/Equity: 0.08
Quick Ratio: 2.23
Current Ratio: 3.00
Price/Book: 7.94
Price/Earnings: 40.17
EBITDA: $205M
EPS: 1.87
Our Approach

Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Sell.

TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.

Contact @ support@theoryofstocks.com

© 2024 Stock Articles. All rights reserved.

This site uses cookies to ensure the best experience. By continuing to use this site, you agree to their use.

Click here for Cookie Policy